Evaluation of multifunctional liposomes in human blood serum by light scattering

Langmuir

Volumn 30, Issue 49, 2014, Pages 14954-14962

  Mohr, Kristin ^a,b   Müller, Sophie S ^a   Müller, Laura K ^b   Rusitzka, Kristiane ^a   Gietzen, Sabine ^a   Frey, Holger ^a   Schmidt, Manfred ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CHEMICAL MODIFICATION; CHOLESTEROL; DYNAMIC LIGHT SCATTERING; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LIPIDS; POLYETHYLENE GLYCOLS;

AGGREGATE FORMATION; CRYO-TRANSMISSION ELECTRON MICROSCOPY; FUNCTIONALIZATIONS; FUNCTIONALIZED; HYDROXYL GROUPS; HYPERBRANCHED POLYETHERS; HYPERBRANCHED POLYGLYCEROL; UNILAMELLAR VESICLE;

LIPOSOMES;

CHOLESTEROL; GLYCEROL; LIPID; LIPOSOME; POLYGLYCEROL; POLYMER;

BIOLOGICAL MODEL; BLOOD; BLOOD ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY;

BLOOD CHEMICAL ANALYSIS; CHOLESTEROL; GLYCEROL; HUMANS; LIPIDS; LIPOSOMES; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; POLYMERS;

EID: 84918784137     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la502926e     Document Type: Article

References (48)

1. Gregoria, G.; Wills, E. J.; Swain, C. P.; Tavill, A. S. Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1974, 1, 1313-1316.
2. Sharma, A.; Sharma, U. S. Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. 1997, 154, 123-140.
3. Lian, T.; Ho, R. J. Y. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001, 90, 667-680.
4. Allen, T. M.; Chonn, A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 1987, 223, 42-46.
5. Woodle, M. C.; Lasic, D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992, 1113, 171-199.
6. Lasic, D. D.; Papahadjopoulos, D. Liposomes revisited. Science 1995, 267, 1275-1276.
7. Immordino, M. L.; Dosio, F.; Cattel, L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed. 2006, 1, 297-315.
8. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1991, 1066, 29-36.
9. Woodle, M. C.; Matthay, K. K.; Newman, M. S.; Hidayat, J. E.; Collins, L. R.; Redemann, C.; Martin, F. J.; Papahadjopoulos, D. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1992, 1105, 193-200.
10. Torchilin, V. P.; Omelyanenko, V. G.; Papisov, M. I.; Bogdanov, A. A.; Trubetskoy, V. S.; Herron, J. N.; Gentry, C. A. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta 1994, 1195, 11-20.
11. Blume, G.; Cevc, G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta 1990, 1029, 91-97.
12. Needham, D.; McIntosh, T. J.; Lasic, D. D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1992, 1108, 40-48.
13. Allen, T. M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv. Drug Delivery Rev. 1994, 13, 285-309.
14. Cabanes, A.; Tzemach, D.; Goren, D.; Horowitz, A. T.; Gabizon, A. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. Clin. Cancer Res. 1998, 4, 499-505.
15. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 2005, 4, 145-160.
16. Lasic, D. D. Doxorubicin in sterically stabilized liposomes. Nature 1996, 380, 561-562.
17. Allen, T. M.; Murray, L.; Mackeigan, S.; Shah, M. Chronic liposome administration in mice-Effects on reticuloendothelial function and tissue distribution. J. Pharmacol. Exp. Ther. 1984, 229, 267-275.
18. Chonn, A.; Semple, S. C.; Cullis, P. R. Association of blood proteins with large unilamellar liposomes in vivo-Relation to circulation lifetimes. J. Biol. Chem. 1992, 267, 18759-18765.
19. Semple, S. C.; Chonn, A.; Cullis, P. R. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Delivery Rev. 1998, 32, 3-17.
20. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Delivery Rev. 2009, 61, 428-437.
21. Liu, Z.; Jiao, Y.; Wang, T.; Zhang, Y.; Xue, W. Interactions between solubilized polymer molecules and blood components. J. Controlled Release 2012, 160, 14-24.
22. Mahon, E.; Salvati, A.; Baldelli Bombelli, F.; Lynch, I.; Dawson, K. A. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J. Controlled Release 2012, 161, 164-174.
23. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; A˚berg, C.; Mahon, E.; Dawson, K. A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol 2013, 8, 137-143.
24. Mohr, K.; Sommer, M.; Baier, G.; Schöttler, S.; Okwieka, P.; Tenzer, S.; Landfester, K.; Mailänder, V.; Schmidt, M.; Meyer, R. G. Aggregation behavior of polystyrene-nanoparticles in human blood serum and its impact on the in vivo distribution in mice. J. Nanomed. Nanotechnol. 2014, DOI: 10.4172/2157-7439.1000193.
25. Pitek, A. S.; O'Connell, D.; Mahon, E.; Monopoli, M. P.; Baldelli Bombelli, F.; Dawson, K. A. Transferrin coated nanoparticles: Study of the bionano interface in human plasma. PLoS One 2012, 7, e40685.
26. Lasic, D. D.; Martin, F. J.; Gabizon, A.; Huang, S. K.; Papahadjopoulos, D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1991, 1070, 187-192.
27. Rausch, K.; Reuter, A.; Fischer, K.; Schmidt, M. Evaluation of nanoparticle aggregation in human blood serum. Biomacromolecules 2010, 11, 2836-2839.
28. Hofmann, A. M.; Wurm, F.; Hühn, E.; Nawroth, T.; Langguth, P.; Frey, H. Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: Toward multifunctional stealth liposomes. Biomacromolecules 2010, 11, 568-574.
29. Hofmann, A. M.; Wurm, F.; Frey, H. Rapid access to polyfunctional lipids with complex architecture via oxyanionic ring-opening polymerization. Macromolecules 2011, 44, 4648-4657.
30. Kainthan, R. K.; Gnanamani, M.; Ganguli, M.; Ghosh, T.; Brooks, D. E.; Maiti, S.; Kizhakkedathu, J. N. Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials 2006, 27, 5377-5390.
31. Wilms, D.; Wurm, F.; Nieberle, J.; Böhm, P.; Kemmer-Jonas, U.; Frey, H. Hyperbranched polyglycerols with elevated molecular weights: A Facile two-step synthesis protocol based on polyglycerol macroinitiators. Macromolecules 2009, 42, 3230-3236.
32. Wilms, D.; Stiriba, S.-E.; Frey, H. Hyperbranched polyglycerols: From the controlled synthesis of biocompatible polyether polyols to multipurpose applications. Acc. Chem. Res. 2010, 43, 129-141.
33. Calderon, M.; Quadir, M. A.; Sharma, S. K.; Haag, R. Dendritic polyglycerols for biomedical applications. Adv. Mater. 2010, 22, 190-218.
34. Siegers, C.; Biesalski, M.; Haag, R. Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins. Chem. - Eur. J. 2004, 10, 2831-2838.
35. Kainthan, R. K.; Zou, Y.; Chiao, M.; Kizhakkedathu, J. N. Self-assembled monothiol-terminated hyperbranched polyglycerols on a gold surface: A comparative study on the structure, morphology, and protein adsorption characteristics with linear poly(ethylene glycol)s. Langmuir 2008, 24, 4907-4916.
36. Knop, K.; Hoogenboom, R.; Fischer, D.; Schubert, U. S. Poly(ethylene glycol) in drug delivery: Pros and cons as well as potential alternatives. Angew. Chem., Int. Ed. 2010, 49, 6288-6308.
37. Fitton, A. O.; Hill, J.; Jane, D. E.; Millar, R. Synthesis of simple oxetane carrying reactive 2-substituents. Synthesis 1987, 12, 1140-1142.
38. Zhao, X. B.; Muthusamy, N.; Byrd, J. C.; Lee, R. J. Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. J. Pharm. Sci. 2007, 96, 2424-2435.
39. Peng, X.; Hofmann, A. M.; Reuter, S.; Frey, H.; Kressler, J. Mixed layers of DPPC and a linear poly(ethylene glycol)-b-hyperbranched poly(glycerol) block copolymer having a cholesteryl end group. Colloid Polym. Sci. 2012, 290, 579-588.
40. Rao, Z.; Taguchi, T. Spectroscopic studies on interactions between cholesterol-end capped polyethylene glycol and liposome. Colloids Surf., B 2012, 97, 248-253.
41. Fritz, T.; Hirsch, M.; Richter, F. C.; Müller, S. S.; Hofmann, A. M.; Rusitzka, K. A.; Markl, J.; Massing, U.; Frey, H.; Helm, M. Click modification of multifunctional liposomes bearing hyperbranched polyether chains. Biomacromolecules 2014, 15, 2440-2448.
42. Schöps, R.; Amado, E.; Müller, S. S.; Frey, H.; Kressler, J. Block copolymers in giant unilamellar vesicles with proteins or with phospholipids. Faraday Discuss. 2013, 166, 303-315.
43. Müller, S. S.; Dingels, C.; Hofmann, A. M.; Frey, H. Polyether-Based Lipids Synthesized with an Epoxide Construction Kit: Multivalent Architectures for Functional Liposomes. In Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications; Scholz, C., Kressler, J., Eds; ACS Symposium Series; American Chemical Society: Washington, DC, 2013; pp 11-25.
44. Wurm, F.; Nieberle, J.; Frey, H. Double-hydrophilic linear-hyperbranched block copolymers based on poly(ethylene oxide) and poly(glycerol). Macromolecules 2008, 41, 1184-1188.
45. Wurm, F.; Nieberle, J.; Frey, H. Synthesis and characterization of poly(glyceryl glycerol) block copolymers. Macromolecules 2008, 41, 1909-1911.
46. Owens, D. E.; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
47. Shi, B.; Fang, C.; Pei, Y. Stealth PEG-PHDCA niosomes: Effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J. Pharm. Sci. 2006, 95, 1873-1887.
48. Hemmelmann, M.; Mohr, K.; Fischer, K.; Zentel, R.; Schmidt, M. Interaction of pHPMA-pLMA copolymers with human blood serum and its components. Mol. Pharmaceutics 2013, 10, 3769-3775.